RECRUITING

Vagal Stimulator to Reduce Nasogastric Tube Use

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Abdominal surgery, laparoscopic or open, is frequently performed at UPMC Shadyside hospital. One of the most frequent complications following abdominal surgery is a postoperative ileus. Although postoperative ileus may be the result of obstruction or leakage, in most cases postoperative ileus (POI) is the result of local irritation because of fluid overload, exogenous opioids, neurohormonal dysfunction, gastrointestinal stretch, local bleeding and inflammation. POI usually lasts between 2 to 7 days. In most cases, a nasogastric tube (NG tube) is used to relieve that gastric pressure until the resolution of the POI. The placement of a NG tube can lead to a local trauma, bleeding and pain. Pain represents a major complaint among those with POI, often contributing to prolonged hospital stays.

Official Title

The Role of a Vagal Stimulator to Reduce the Frequency and Duration on Nasogastric Tube Following Abdominal Surgery

Quick Facts

Study Start:2024-12-04
Study Completion:2026-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06648759

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults (18 and older) undergoing laparoscopic or open colorectal surgery, or any major abdominal surgeries at UPMC Shadyside
  2. * Development of post-operative ileus
  3. * Anticipation of a nasogastric (ng) tube being placed
  1. * Pregnant subjects
  2. * Subjects who are unable to read, write, or speak English fluently
  3. * Subjects who have a developmental or neurological disorder and are not cognitively able to provide consent

Contacts and Locations

Study Contact

Carly Riedmann, MPH
CONTACT
412-623-4147
riedmannca@upmc.edu
Amy Monroe, MPH, MBA
CONTACT
monroeal@upmc.edu

Principal Investigator

Jacques E Chelly, MD, PhD, MBA
PRINCIPAL_INVESTIGATOR
University of Pittsburgh, UPMC

Study Locations (Sites)

UPMC Shadyside Hospital
Pittsburgh, Pennsylvania, 15232
United States

Collaborators and Investigators

Sponsor: Jacques E. Chelly

  • Jacques E Chelly, MD, PhD, MBA, PRINCIPAL_INVESTIGATOR, University of Pittsburgh, UPMC

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-04
Study Completion Date2026-09-30

Study Record Updates

Study Start Date2024-12-04
Study Completion Date2026-09-30

Terms related to this study

Additional Relevant MeSH Terms

  • Nasogastric Tube Intubation